Joel Schlessinger M.D.

Joel Schlessinger MD took part in a study published in the July 2011 Aesthetic Surgery Journal that evaluated the efficacy of a tretinoin/hydroquinone regimen along with users of Botox (botulinum toxin Type A) for improvement in facial skin and appearance.

This study was performed by three different researchers, one of which was Joel Schlessinger MD. This randomized study was performed on 61 patients who received Botox treatments and then were randomly selected to use either the tretinoin/hydroquinone regimen or a standard skin care regimen for 120 days.

Those that received the tretinoin/hydroquinone regimen experienced milder fine lines, wrinkles and hyperpigmentation as well as significantly better overall ratings of the system.

Joel Schlessinger MD and colleagues concluded that using a tretinoin/hydroquinone regimen can clearly enhance improvements of a Botox treatment.

LovelySkin.com carries a wide range of 4% hydroquinone products that can be used after a cosmetic procedure. Joel Schlessinger MD suggests the Obagi Nu-Derm System, a comprehensive set of 4% hydroquinone products that dramatically improve the tone and texture of your skin.

To add tretinoin into your 4% hydroquinone regimen, consult with your local dermatologist.

Read more about “Further enhancement of facial appearance with a hydroquinone skin care system plus tretinoin in patients previously treated with butulinum toxin Type A.”